molecular genetic test

molecular genetic test

Cytogenetic test, molecular cytogenetic test Molecular medicine The analysis of human DNA, RNA, and chromosomes to detect heritable or acquired disease-related genotypes, mutations, phenotypes, or karyotypes for clinical purposes, which include predicting risk of disease, identifying carriers, and establishing prenatal or clinical diagnoses or prognoses. See Applied genomics.
Mentioned in ?
References in periodicals archive ?
The "DNA sequence of a gene" or "of a gene region" is often perceived as the ultimate result of a molecular genetic test.
In their respective reports, both EQUALseq (4) and EMQN (5) clearly demonstrate that there is room for improvement and that EQA is essential for assessing the quality of the molecular genetic tests being performed and the test reports being issued.
Molecular pathology laboratories must take many factors into account before deciding whether to offer a molecular genetic test.
Contract notice: Id15rea001 - open procedure for the signing of an agreement for the assignment of the supply in full service of analytic systems for molecular genetic tests.
This is important because most clinical molecular genetic tests are developed by individual laboratories and are not available as commercial test kits that are manufactured and evaluated in a consistent manner.
Multiplicom NV, a specialist in the development, production and commercialization of innovative molecular genetic tests based on massively parallel sequencing (MPS), today announces that it is launching a CE/IVD labeled MID kit for Illumina MiSeq together with three new germline mutation detection MASTR[sup.
General recommendations for quality assurance programs for laboratory molecular genetic tests, final monograph.
Multiplicom NV, a specialist in the development, production and commercialization of innovative molecular genetic tests based on massively parallel sequencing (MPS), today announces that it is launching three new somatic mutation detection kits which will enable users to implement personalized cancer treatment at an unprecedented level.
Molecular genetic tests and cytogenetic tests are described in the GTS's definition as the analysis of human DNA, RNA, and chromosomes to detect heritable or acquired disease-related genotypes, mutations, pheno-types, or karyotypes for clinical purposes.
Multiplicom NV, a specialist in the development, production and commercialisation of innovative molecular genetic tests, today announces that Dr Ian Gilham has been appointed as Chairman of the Board of Directors.
Despite this impressive growth in disease offerings over a relatively short period, the CAP/ACMG Resource Committee has long been concerned about an inability to keep up with the growth of molecular genetic tests in the field.
However, for many other molecular genetic tests, interlaboratory comparison programs such as the one conducted by Lutz et al.

Full browser ?